HOME       Contact Us      Hire Us       Domestic Airlines        Railway Enquiry     Railway Booking     Hotels Abroad
NEIGHBOURS CALLING:      Dubai      Malaysia     Nepal     Bhutan
indiatraveltimes.com
CORONAVIRUS CASUALTIES (Nov 18):- GLOBAL:- Total Cases: 5,61,57,049; Total Deaths: 13,47,459 Recovered: 3,91,20,688 BELGIUM:- Total Cases: 5,40,605; Total Deaths: 14,839 BRAZIL:- Total Cases: 59,12,903; Total deaths: 1,66,847 CANADA:- Total Cases: 3,07,885; Total Deaths: 11,118 CHINA:- Total Cases: 86,369 ; Total Deaths: 4,635 FRANCE:- Total Cases: 20,36,755; Total Deaths: 43,892 GERMANY:- Total Cases: 8,41,097; Total Deaths: 13,318 INDIA:- Total Cases: 89,25,467; Total Deaths: 1,31,130 INDONESIA:- Total Cases: 4,78,720; Total Deaths: 15,503 IRAN:- Total Cases: 8,01,894; Total Deaths: 42,941 ITALY:- Total Cases: 12,38,072; Total Deaths: 46,464 JAPAN:- Total Cases: 1,20,815; Total Deaths: 1,913 MEXICO:-Total Cases: 10,11,153; Total Deaths: 99,026 NETHERLANDS:- Total Cases: 4,61,612; Total Deaths: 8,698 PHILIPPINES:- Total Cases: 412,097; Total Deaths: 7,957 RUSSIA:- Total Cases: 19,91,998; Total Deaths: 34,387 S KOREA:- Total Cases: 29,311; Total Deaths: 496 SPAIN:-Total Cases: 15,35,058; Total Deaths: 41,688 SWEDEN:- Total Cases: 1,96,446 Total Deaths: 6,321 SWITZERLAND:-Total Cases: 2,80,648; Total Deaths: 3,726 UAE:- Total Cases: 1,54,101; Total Deaths: 542 UK:- Total Cases: 14,10,732; Total Deaths: 52,745; US:- Total Cases: 1,17,09,384; Total Deaths: 2,54,463 - India Travel Times.Com   [Estd: 1998]       * * *    Travel, More Travel, Travel Means A Million Things     * * *    
Cipla's Favipiravir branded as Ciplenza priced at Rs 68 per tablet to be available by Aug first week
Favipiravir has shown promising results in fighting covid in mild and moderate cases. Glenmark's reduced price of its Favipiravir branded as FabiFlu is Rs 75 per tablet and the treatment for 14 days costs Rs 10,200.

NEW DELHI, July 25: Cipla-produced anti-viral, re-purposed Favipiravir, brand-named as Ciplenza, was given regulatory nod by DCGI on Friday to sell the drug in the market. It will be available through hospital channels for use under emergency authorisation from the first week of August for Rs 68 per tablet.

Favipiravir is an anti-viral drug developed by Fuji Pharma of Japan. It is now re-purposed as a therapy for coronavirus. It shows promising results in fighting covid in mild and moderate cases. It is off-patented and Cipla is launching it in India.

It has been reported that CSIR-IICT developed a cost-effective process using locally available chemicals to synthesise the Active Pharmaceutical Ingredient (API) and transferred the technolgy to Cipla.

Meanwhile, Glenmark Pharma has reduced the price of its Favipiravir branded as FabiFlu by 27% to Rs 75 per tablet from Rs 103 after the DCGI wrote that the price was too high for the poor patients of coronavirus. The treatment cost of a 14-day regimen will come down to Rs 10,200 from Rs14,000. The pharma had received manufacturing and marketing approval from the DCGI last month after It had completed the phase 3 clinical trial in mild to moderate covid patients in India.

Glenmark is also trying a combination therapy using Umifenovir in moderate hospitalised cases.

Previous Files
ARCHIVES



Neighbours
Calling

Bhutan
Nepal
Malaysia
Dubai

Dalai Lama discharged from hospital in New Delhi
Fashion & Lifestyle
Yoga & Asanas
Fairs, Festivals & Melas
Religion & Cult
Pilgrimage
Art & Culture
History, Legends & Mythology
Ayurveda
Free Ayurveda Consultation
ARCHIVES
A Window On India
Fashion & Lifestyle
Yoga & Asanas
Fairs, Festivals & Melas
Religion & Cult
Pilgrimage
Art & Culture
History, Legends & Mythology
Ayurveda
News (Archives)
Travel News
Travel News Archives
Travel News Index

Custom Search